Background and Aim: The aim of this study was to assess the performance of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for the diagnosis of gastric linitis plastic (GLP). Methods: We retrospectively reviewed all the cases undergoing EUS for suspected GLP from January 2012 to September 2017. We included patients with GLP confirmed pathologically with white-light endoscopy (WLE)-guided biopsy or EUS-FNA. Diagnostic value of WLE biopsy and EUS-FNA was further analyzed. Results: A total of 107 cases of suspected GLP were referred for EUS examination in our center. Twenty-six patients were eligible and included. GLP was confirmed in 15 cases by EUS-FNA, nine cases by WLE biopsy, and eight cases by surgical pathology. The positive rate of EUS-FNA and WLE biopsy for involved gastric wall was 71.43% (15/21) and 47.37% (9/19). EUS-FNA of metastatic lymph nodes was also performed in 16 cases, and 15 (93.75%) were proved to be malignant, including all 13 that were positive for peri-gastric lymph nodes, and two of three (66.67%) that were positive rate for retroperitoneal lymph nodes. Diameters of punctured lymph nodes ranged from 3.30 to 22.70 mm, with an average of 12.12 mm. Conclusions: Pathological diagnosis of GLP by invasive endoscopy is still intractable, even at a late stage. Positive results can be obtained even in small or distant lymph nodes.
Introduction
Gastric linitis plastica (GLP), which was also known as Borrmann type IV or diffuse infiltrating type gastric cancer or scirrhous carcinoma, is a diffuse, infiltrating carcinoma characterized by thickening and rigidity of the stomach wall. 1 There has been a striking increase in the incidence of GLP. According to recent studies, GLP composed 32-70% of gastric cancer cases in western countries. 2, 3 This type of gastric cancer is associated with poor prognosis as the disease is often diagnosed at an advanced stage, and some attribute this to the specific clinicopathological characteristics of the tumor. 4, 5 Other studies have attributed this to difficulties in detecting the presence of gastric carcinoma under endoscopic inspection, as there is usually no ulceration or elevation appearing on the mucosal surface at the early stage of this malignancy. 6 Conventional white-light endoscopy (WLE)-guided biopsy was only available for mucosal lesions and ineffective for pathological diagnosis of GLP, with a high false-negative rate. 7, 8 Endoscopic ultrasound (EUS) was proved to be the key imaging method for clear description of the five sonographic layers of the gastric wall and adjacent lymph nodes. It has been reported that EUS is helpful for GLP surveillance and staging. 2, 9 Tissues can be acquired by EUS-guided fine-needle aspiration (EUS-FNA). EUS-FNA is widely used for obtaining diagnostic cellularity in primary lesions and metastatic lymph nodes of tumors. However, only a few studies have described the application of EUS-FNA for diagnosis of GLP. In this study, we aimed to compare the diagnostic value of WLE biopsy and EUS-FNA in involved gastric wall or metastatic lymph nodes in the diagnosis of GLP.
Materials and methods
Patient selection. We reviewed patients with suspected GLP who were referred for EUS at the Shanghai Cancer Center of Fudan University from January 2012 to September 2017. The inclusion criteria included (i) gastric lesions suspected of GLP in routine endoscopy, EUS, or other imaging modalities; (ii) clinical records and EUS features were available in the electronic database; and (iii) final diagnosis was confirmed by surgical biopsy pathology or FNA-directed cytology. Patients received medical treatment (e.g. radiotherapy or chemotherapy) before EUS, or a coexisting secondary tumor was excluded. This study was approved by the Institutional Review Board of our hospital. Informed consent was obtained from all individual patients in this study.
Methods. Two experienced endoscopists in our center performed all the EUS and FNA procedures. Linear EUS (EG-3870UTK and EG-3270UK; Pantax, Tokyo, Japan) were applied in all cases, based on the Hitachi Preirus Platform (Hitachi, Tokyo, Japan). With fasting for >8 h, patients' stomach and adjacent tissues were checked with EUS by using bladders and (or) degassed water filling method. Location, depth of invasion, thickness of involved gastric wall, and metastatic lymph nodes were checked and recorded. As GLP had two characteristic EUS features showed in our study and we also referred to the previous report of Shan et al.,
2 the cases were divided into two groups to dichotomize the severity of involved gastric wall. Group A: GLPs with five sonographic layers of injury and hypoechogenic thickening, even invasion outside the serosa in some cases. Group B: cases in which blurring and thickness were only confined in up to four sonographic layers.
EUS-FNA procedures were performed under conscious sedation with intravenous midazolam and fentanyl. Lymph nodes were considered to be metastatic by EUS imaging by the presence of at least three of the following criteria: round shape, hypoechogenicity, well-defined borders, or diameter >10 mm. Puncture sites were always set as the involved gastric wall with the worst damage or metastatic lymph nodes. When targeted sites were located, a 19-, 22-, or 25-gauge Echo Tip Ultra or Precore needle (Cook Endoscopy, Limerick, Ireland) was applied, directed by endoscopist's preference, characteristic, and location of lesion. After inserting the needle into the echoendoscope, the endoscopists repositioned the echoendoscope to locate the lesion at desired position and advanced the needle. A 5-to 10-mL syringe was set to activate the suction. Color Doppler US was used to distinguish vascular structures during FNA. During the procedure, high-resolution imaging provided by the linear EUS ensured precise distinction of the lesion margins; elastography and fine-flow imaging were selected based on the different acoustic features of the lesions to provide valuable information about tissue elasticity (hardness) and microvascular perfusion. Aspirated materials were smeared onto two slides and placed to dry for rapid onsite evaluation, which was performed by the endoscopists. When diagnostic materials were confirmed on the slide, the remaining material was collected for cell blocks, and visible tissue fragments were removed for formalin fixation. If the first needle pass of the involved gastric wall yielded a positive result, then we sampled three needle passes of the involved gastric wall and finished the procedure. If the first needle pass yielded a negative result, then gastric wall lesions or metastatic lymph nodes were sampled for 1-3 needle passes until a definitive diagnosis was made by rapid onsite evaluation. After EUS-FNA, all the materials were delivered to the pathology department for final diagnosis.
White-light endoscopy biopsy was performed under conventional WLE imaging. The presence and extent of GLP were determined according to enlarged or effaced rugal folds, circumferentially infiltrating lesions, or loss of dispensability despite air insufflation associated with hyperemic mucosal change and small erosions. [10] [11] [12] The diagnosis and longitudinal extent of the tumor were recorded according to the Japanese Classification of Gastric Cancer. 13 Six to eight biopsies from multiple sites were performed for each case.
Statistical analysis. Data were analyzed using SPSS statistical software (SPSS, Chicago, IL, USA). Continuous variables were expressed as mean ± SD. The χ 2 test and Fisher's exact test were applied for comparison of rates. For all analyses, values of P < 0.05 were considered to be significant.
Results
A total of 107 cases of suspected GLP were referred for EUS examination in our center (Fig. 1) . After checking the archive, 26 cases were confirmed by pathological standards and delivered for further analysis, including 17 women and 9 men, aged 29-70 years (mean 54 years). As shown in Table 1 , pathological evidence in 15 cases was derived from EUS-FNA of the thickened gastric wall, in nine cases from WLE biopsy, and in eight cases from surgical resection. The histological classification included poorly to moderately differentiated adenocarcinoma (n = 18), signet ring cell carcinoma (n = 7), and adenosquamous carcinoma (n = 1).
As shown by EUS, diffuse thickening of the involved gastric wall in different layers was the typical feature of GLP. In the quantitative description of EUS, thickness of involved gastric wall ranged from 8.3 to 22.7 mm, with an average of 12.86 mm. Sixteen of the 26 cases were manifested with Group A features, and 10 cases were manifested with Group B features, and representative images are shown in Figure 2 .
Endoscopic ultrasound-guided fine-needle aspiration of involved gastric wall was performed in 21 cases (Fig. 3a) , and 15 cases were proved to be adenocarcinoma by cytopathology. Nineteen cases underwent WLE biopsy (Fig. 3b) and nine pathological diagnosis. EUS-FNA showed a higher positive rate than WLE biopsy showed, 71.43% (15/21) and 47.37% (9/19), but the difference was not significant (P = 0.12). We also compared the positive rate for the two methods between involved gastric wall with Groups A and B features, as described earlier. As shown in Table 2 , no significant difference was obtained for the two methods, P = 1.00 for EUS-FNA and WLE biopsy.
Three cases underwent laparoscopic radical gastrectomy, suggested by the multidisciplinary team discussion, after repetitive negative results for WLE biopsy and EUS-FNA.
Peri-gastric and retroperitoneal metastatic lymph nodes were detected in 88.46% (23/26) cases and punctured by EUS-FNA in 16 cases (Fig. 3c) . Diameters of the punctured lymph nodes ranged from 3.3 to 22.7 mm, with six lymph nodes (<10 mm) and 10 lymph nodes (>10 mm). The positive rate of EUS-FNA was 93.75% (15/16), including 100% (13/13) for peri-gastric lymph nodes and 66.67% (2/3) for retroperitoneal lymph nodes ( Table 3 ). The only negative case was the smallest one, which had a diameter of 3.3 mm.
No severe complications including hemorrhage or perforation were recorded in all included cases during the procedures.
Discussion
Gastric linitis plastic is a gastric cancer of diffuse histotype that always presents in the fundic gland area and is characterized by poorly differentiated carcinoma that diffusely infiltrates the gastric wall, thus leading to reactive fibrosis. 8 Endoscopic characteristics of GLP included poor distension of the gastric walls and morphological changes of giant, swollen, straight, furrowed, and crossed folds. 8 
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Waffle-like appearance is another diagnostic feature for GLP, as presented by endoscopy. 8 Histopathological findings are essential to the diagnosis and therapeutic decision-making in Borrmann type IV gastric cancer. Histopathological diagnosis is the gold standard for Borrmann type IV gastric cancer that is required by medical ethics and practice guidelines. 4 Early diagnosis of Borrmann type IV cancer is difficult. The unique morphological features always lead to indeterminate or nondiagnostic results in repeated biopsies, and further diagnosis mainly relies on deterioration of the clinical course. 7 Hence, some have suggested that when GLP is highly suspected by imaging modalities (like radiography, endoscopy, or EUS), and in the absence of positive pathological evidence, surgical intervention should be considered. 7, 14, 15 In our study, the three cases that presented with repeated negative biopsy results were finally accepted for surgical resection, as recommended by multidisciplinary team discussion. The final pathological diagnosis was consistent with the doctor's judgment. In the clinical algorithm, critical clues were the radiography, endoscopy, and EUS features, while surgical resection was requisite for the definite diagnosis.
Endoscopic ultrasound was proved to be superior for the detection of involved gastric wall and peri-gastric injury. Furthermore, EUS-FNA allowed acquisition of samples for cytological examination of gastrointestinal tumors. 16 FNA was once considered to be feasible for obtaining samples from deeper sites of the gastric wall and had a higher positive rate than conventional WLE biopsy had. 17 Although the result was not statistically significant, the positive rate of EUS-FNA for involved gastric wall was higher than for WLE biopsy in our study. GLPs were divided into two groups, based on involved gastric wall features in EUS, and reflected by different severity. Our data indicated that the positive rates for the two methods did not differ significantly and did not increase with disease severity. Hence, in our experience, obtaining pathological diagnosis might still be tough for GLP at a late stage. Endoscopic ultrasound-guided fine-needle aspiration Y Liu et al.
Lymphadenopathy was another indication for EUS-FNA, such as primary or metastatic malignancy. It is reported that EUS-FNA performs well for discriminating between malignant and inflammatory lymph nodes, with a specificity of 95%. 9 The incidence and extent of lymph node metastasis are closely correlated with degree of malignancy, location, TNM stage, and other biological characteristics of gastric cancer. As treatment decisions depend on lymph node as well as distant metastasis staging, histological or cytological characterization of the suspected metastatic lesion is of importance.
9 EUS-FNA can obtain pathological findings of metastatic lymph nodes and make N staging more accurate. 18 Pathological findings of metastatic lymph nodes also gives clues regarding the nature and origin of primary tumor. 19 In our study, EUS-FNA was performed by needle penetration at multiple sections within the lesions via a 3-D route. In this manner, even with small lymph nodes <10 mm, aspiration was also feasible and the materials were diagnostic. Finally, the positive rate of EUS-FNA for all the metastatic lymph nodes was 93.75%. The minimum diameter of the lymph nodes was 3.8 mm. With EUS scanning, all the peri-gastric lymph nodes were visible. In our experience, FNA of lymph nodes located along the truncus celiacus was also successful and positive cytology was obtained. All the results indicated that EUS-FNA would be a superior way of N staging for GLP and should be done combine with WLE biopsy or EUS-FNA of involved gastric wall during EUS procedure for proper patients. There were several limitations to our study. It was a retrospective and single center study. While there appeared to be a large difference between the diagnostic confirmation using EUS-FNA and WLE biopsy, the difference was not significant, and this might have been due to the limited number of cases. For inclusion of all GLP cases confirmed by pathology, we enrolled cases that were positive by WLE biopsy and EUS-FNA for involved gastric wall, which might have resulted in selection bias. Larger sample size and better designed prospective studies are warranted to reach a more accurate conclusion in the future.
In conclusion, pathological diagnosis of GLP by invasive endoscopy was still intractable, even at a late stage. Although EUS-FNA of involved gastric wall had no significant advantage compared with WLE biopsy, our data indicated that puncture of metastatic lymph nodes was feasible and highly diagnostic. Positive results were achieved even in small or distant lymph nodes.
